ClinicalTrials.gg
Not yet recruitingNCT07719270Updated Jul 22, 2026

Management of Postoperative Complications After Mandibular Third Molar Extraction Using Submucosal Triamcinolone Injection, Kinesiology Taping, and Standard Care

An interventional study of Triamcinolone Acetonide 10mg and Kinesiology Taping in Trismus, Edema and Pain, sponsored by Allama Iqbal Medical College. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Allama Iqbal Medical College · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The surgical removal of impacted lower wisdom teeth (mandibular third molars) frequently leads to uncomfortable postoperative symptoms, including pain, facial swelling (edema), and restricted jaw movement (trismus). This study aims to evaluate and compare the effectiveness of two different treatment strategies alongside standard care to reduce these complications.

A total of 60 patients undergoing surgical extraction will be randomly assigned to one of three groups: Group A will receive a local submucosal injection of 10mg Triamcinolone (a corticosteroid), Group B will have Kinesiology Tape applied to the face to enhance fluid drainage, and Group C will receive standard postoperative care alone. Patient recovery outcomes, including pain levels, facial swelling, and jaw mobility, will be monitored and measured at 24 hours, 3 days, and 7 days after the surgery. The study's primary objective is to determine if adding either a pharmacological injection or a mechanical tape significantly improves patient recovery compared to standard postoperative care alone.

Read the detailed description

Surgical extraction of impacted mandibular third molars inevitably induces soft tissue trauma and bone disruption, triggering an acute inflammatory cascade primarily driven by arachidonic acid metabolites. This trial evaluates a head-to-head comparison between a localized pharmacological agent (corticosteroid) and a non-invasive mechanical intervention (kinesiology taping) to manage post-surgical sequelae.

Triamcinolone Acetonide is a potent synthetic corticosteroid designed to inhibit early-stage inflammatory pathways. Its submucosal administration aims to achieve high local drug concentration at the trauma site while minimizing systemic absorption risks. Conversely, Kinesiology Taping (KT) offers a non-pharmacological approach by microscopically lifting the skin over the masseteric region. This action is intended to reduce interstitial pressure, enhance local microcirculation, and accelerate lymphatic drainage.

This randomized controlled trial evaluates 60 eligible patients divided equally into three arms (n=20 per group):

  1. Group A: 10 mg Submucosal Triamcinolone combined with standard postoperative care.
  2. Group B: Face-applied Kinesiology Taping combined with standard postoperative care.
  3. Group C: Standard postoperative care alone (Control). Clinical outcomes including pain severity, facial swelling, and trismus will be quantified across three distinct postoperative follow-up intervals: 24 hours, 3 days, and 7 days. The gathered data will be analyzed to establish evidence-based guidance on optimizing patient comfort and recovery speed.
02

Conditions studied

  • Trismus
  • Edema
  • Pain

Keywords

  • Triamcinolone Acetonide
  • Kinesiology Taping
  • Third Molar Extraction
  • Maxillofacial Surgery
03

In context

Trismus

107 studies on the registry are indexed under Trismus; 19 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 99 interventional studies indexed under Trismus.

Browse Trismus studies →

Lead sponsor

Allama Iqbal Medical College is the lead sponsor of 11 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-40 years
  • Surgical patients requiring extraction of Impacted mandibular third molars

Exclusion criteria

Exclusion Criteria:

  • Known allergy to /adhesive
  • Systemic diseases
  • Active infection
  • Pregnancy and lactation
  • Surgical duration > 45 minutes.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group A (Triamcinolone + Standard Care)

    Patients assigned to receive a single localized submucosal injection of 10mg Triamcinolone Acetonide immediately following surgical extraction of the lower third molar, alongside standard postoperative care.

    Drug: Triamcinolone Acetonide 10mg · Other: Standard Postoperative Care

  • Experimental
    Group B (Kinesiology Taping + Standard Care)

    Patients assigned to receive application of facial Kinesiology Taping (KT) immediately post-surgery to assist with lymphatic drainage, alongside standard postoperative care.

    Device: Kinesiology Taping · Other: Standard Postoperative Care

  • Other
    Group C (Standard Care Alone)

    Patients assigned to receive standard postoperative pharmacological care alone (such as prescribed oral analgesics and routine post-extraction instructions) with no additional localized intervention.

    Other: Standard Postoperative Care

Interventions

  • Single local submucosal injection of 10mg Triamcinolone Acetonide administered immediately after third molar surgical extraction.

  • DeviceKinesiology Taping

    Elastic kinesiology tape applied over the masseteric region immediately after surgery to assist in tissue decompression and lymphatic flow.

  • OtherStandard Postoperative Care

    Standard pharmacological regimen (routine oral analgesics/antibiotics) and post-operative home-care instructions.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Severity

    Postoperative pain severity will be assessed using a 10-point Visual Analog Scale (VAS), where 0 indicates "no pain" and 10 indicates "the worst pain imaginable

    Time frame: Preoperatively (baseline), and at 24 hours, 3 days, and 7 days postoperatively

Secondary outcomes

  1. Postoperative Facial Swelling (Edema)

    Postoperative facial swelling will be assessed using quantitative facial measurements in millimeters (using standard landmark reference points like tragus to corner of the mouth, tragus to soft tissue pogonion, and lateral canthus to gonion)

    Time frame: Preoperatively (baseline), and at 24 hours, 3 days, and 7 days postoperatively

  2. Postoperative Trismus

    Postoperative trismus (limited mouth opening) will be quantified in millimeters by measuring the maximum interincisal distance at maximum active mouth opening using a digital vernier caliper

    Time frame: Preoperatively (baseline), and at 24 hours, 3 days, and 7 days postoperatively.

07

Study locations

1 site
  • Allama Iqbal Medical College & Jinnah Hospital
    Lahore, Punjab Province 54590, Pakistan
08

References and documents

Publications

  • Wilkes MC, Scanlon V, Shibuya A, Cepika AM, Eskin A, Chen Z, Narla A, Glader B, Roncarolo MG, Nelson SF, Sakamoto KM. Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond-Blackfan anemia. Exp Hematol. 2022 Jul;111:66-78. doi: 10.1016/j.exphem.2022.04.005. Epub 2022 Apr 20. PubMed 35460833 ↗
  • Cavalcante DA, Gadelha A, Noto C. How challenging is to manage agitated patients? Braz J Psychiatry. 2019 Jul-Aug;41(4):277-278. doi: 10.1590/1516-4446-2019-4105. No abstract available. PubMed 31365715 ↗
  • Zerener T, Aydintug YS, Sencimen M, Bayar GR, Yazici M, Altug HA, Misir AF, Acikel C. Clinical comparison of submucosal injection of dexamethasone and triamcinolone acetonide on postoperative discomfort after third molar surgery. Quintessence Int. 2015 Apr;46(4):317-26. doi: 10.3290/j.qi.a33281. PubMed 25529005 ↗

Individual participant data

Plan to share: No — I do not plan to make the raw, de-identified spreadsheet containing every individual patient's data publicly downloadable by outside researchers. I will still share the final results and analysis through your published thesis or journal article, which satisfies standard journal requirements.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07719270
Lead sponsor
Allama Iqbal Medical College
Responsible party
Sponsor
First posted
Jul 22, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Jun 1, 2028 (estimated)
Completion
Jan 1, 2029 (estimated)
Last update
Jul 22, 2026

Study contacts

Kashaf Tariq, BDS, FCPS OMFS Resident
Contact
kashaftariq6242@gmail.com
+923326043105
Gulraiz Zulfiqar, BDS, FCPS OMFS, CHPE
study chair · Allama Iqbal Medical College, Lahore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Triamcinolone Acetonide

Start the discussion